Practice
Efficacy of autologous platelet-rich plasma gel in patients with hard-to-heal diabetic foot ulcers: a multicentre study in Japan
Norihiko Ohura; Chu Kimura; Hiroshi Ando; Shunsuke Yuzuriha; Masahide Furukawa; Ryuji Higashita; Shinobu Ayabe; Yoriko Tsuji; Miki Fujii; Yuta Terabe; Masanobu Sakisaka; Yuki Iwashina; Arata Nakanishi; Shigeru Sasaki; Toshio Hasegawa; Tsukasa Kawauchi; Katsuya Hisamichi
Published Online:5 Jul 2024https://doi.org/10.12968/jowc.2023.0088
References
- 1 Incidence of diabetic foot ulcer in Japanese patients with type 2 diabetes mellitus: the Fukuoka diabetes registry. Diabetes Res Clin Pract 2018; 137:183–189. DOI: 10.1016/j.diabres.2018.01.020 Crossref, Medline, Google Scholar
- 2 . Cost-effectiveness analysis for the treatment of diabetic foot ulcer in France: platelet-rich plasma vs standard of care. Clinicoecon Outcomes Res 2022; 14:1–10. DOI: 10.2147/CEOR.S327191 Crossref, Medline, Google Scholar
- 3 . Management of diabetic foot ulcers. Diabetes Ther 2012; 3(1):4 DOI: 10.1007/s13300-012-0004-9 Crossref, Medline, Google Scholar
- 4 . Diabetic foot disease: from the evaluation of the ‘foot at risk’ to the novel diabetic ulcer treatment modalities. World J Diabetes 2016; 7(7):153–164. DOI: 10.4239/wjd.v7.i7.153 Crossref, Medline, Google Scholar
- 5 . Diabetic foot ulcers and their recurrence. N Engl J Med 2017; 376(24):2367–2375. DOI: 10.1056/NEJMra1615439 Crossref, Medline, Google Scholar
- 6 Incidence and risk factors associated with ulcer recurrence among patients with diabetic foot ulcers treated in a multidisciplinary setting. J Surg Res 2020; 246:243–250. DOI: 10.1016/j.jss.2019.09.025 Crossref, Medline, Google Scholar
- 7 Survival and factors predicting mortality after major and minor lower-extremity amputations among patients with diabetes: a population-based study using health information systems. BMJ Open Diabetes Res Care 2020; 8(1):e001355 DOI: 10.1136/bmjdrc-2020-001355 Crossref, Medline, Google Scholar
- 8 Wound Bed Advisory Board Members. Wound bed preparation and a brief history of TIME. Int Wound J 2004; 1(1):19–32. DOI: 10.1111/j.1742-481x.2004.00008.x Crossref, Medline, Google Scholar
- 9 Implementing TIMERS: the race against hard-to-heal wounds. J Wound Care 2019; 23(Sup3a): S1–S50. DOI: 10.12968/jowc.2019.28.Sup3a.S1 Link, Google Scholar
- 10 Growth factors in the pathogenesis of diabetic foot ulcers. Front Biosci (Landmark Ed) 2018; 23(2):310–317. DOI: 10.2741/4593 Medline, Google Scholar
- 11 Platelet gel: a new therapeutic tool with great potential. Blood Transfus 2017; 15(4):333–340. DOI: 10.2450/2016.0038-16 Medline, Google Scholar
- 12 Autologel Diabetic Foot Ulcer Study Group. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage 2006; 52(6):68–74 Medline, Google Scholar
- 13 . Aurix gel is an effective intervention for chronic diabetic foot ulcers: a pragmatic randomized controlled trial. Adv Skin Wound Care 2019; 32(9):416–426. DOI: 10.1097/01.ASW.0000577140.19174.9e Crossref, Medline, Google Scholar
- 14 . Autologous platelet rich plasma (PRP): what do we know? Important concepts relevant to hair restoration surgery. Hair Transplant Forum International 2010; 20(1):14–17. DOI: 10.33589/20.1.0014 Crossref, Google Scholar
- 15 ; Guidance Development Committee for Clinical Trial Protocols for Chronic Wound Treatment Medical Devices. Hard-to-heal wound treatment medical devices: clinical trial protocol in Japan. J Wound Care 2021; 30(8):666–676. DOI: 10.12968/jowc.2021.30.8.666 Link, Google Scholar
- 16 E-Z Graph Wound Assessment Measuring Guide. Wound Reference, 2022. https://tinyurl.com/4rnavz2w (accessed 22 May 2024) Google Scholar
- 17 . NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012; 9(7):671–675. DOI: 10.1038/nmeth.2089 Crossref, Medline, Google Scholar
- 18 Japanese Society of Pressure Ulcers. DESIGN-R scoring manual [English version]. 2014. https://tinyurl.com/mt9e6e8p (accessed 22 May 2024) Google Scholar
- 19 [Dose finding study of G-511 ointinent (prostaglandin E1 Ointinent) in chronic skin ulcers - a double blind randomized clinical study] [in Japanese]. J Clin Therap Med. 1993; 9(12): 2873–2892 Google Scholar
- 20 Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer. Eur J Dermatol 2009; 19(5):461–468. DOI: 10.1684/ejd.2009.0750 Crossref, Medline, Google Scholar
- 21 Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Plast Reconstr Surg 2006; 117(7 supplement):239S–244S. DOI: 10.1097/01.prs.0000222891.74489.33 Crossref, Medline, Google Scholar
- 22 . A post-hoc analysis of reduction in diabetic foot ulcer size at 4 weeks as a predictor of healing by 12 weeks. Ostomy Wound Manage 2010; 56(3):44–50 Medline, Google Scholar
- 23 Fifty percent area reduction after 4 weeks of treatment is a reliable indicator for healing–analysis of a single-center cohort of 704 diabetic patients. J Diabetes Complications 2009; 23(1):49–53. DOI: 10.1016/j.jdiacomp.2008.02.001 Crossref, Medline, Google Scholar
- 24 . Differentiating diabetic foot ulcers that are unlikely to heal by 12 weeks following achieving 50% percent area reduction at 4 weeks. Int Wound J 2011; 8(6):632–637. DOI: 10.1111/j.1742-481X.2011.00860.x Crossref, Medline, Google Scholar
- 25 The management of diabetic foot: a clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. J Vasc Surg 2016; 63(2 Suppl):3S–21S. DOI: 10.1016/j.jvs.2015.10.003 Crossref, Medline, Google Scholar
- 26 . Skin perfusion pressure and wound closure time in lower extremity wounds. J Am Coll Clin Wound Spec 2017; 9(1–3):14–18. DOI: 10.1016/j.jccw.2018.10.001 Medline, Google Scholar
- 27 Japanese Circulation Society and Japanese Society for Vascular Surgery. [Revised guidelines for peripheral arterial disease] [in Japanese]. 2022. https://www.j-circ.or.jp/guideline/guideline-series/ (accessed 12 June 2024) Google Scholar
- 28 ; GVG Writing Group for the Joint Guidelines of the Society for Vascular Surgery, European Society for Vascular Surgery, and World Federation of Vascular Societies. Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg 2019; 58(1S):S1–S109. DOI: 10.1016/j.ejvs.2019.05.006 Crossref, Medline, Google Scholar
- 29 . Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care 1998; 21(5):822–827. DOI: 10.2337/diacare.21.5.822 Crossref, Medline, Google Scholar
- 30 . [Results of clinical study of V.A.C. ATS Therapy System in Japan] [in Japanese]. Jpn J Plast Surg 2010; 53(6):655–662 Google Scholar
- 31 . Concentrations of blood components in commercial platelet-rich plasma separation systems: a review of the literature. Am J Sports Med 2019; 47(2):479–487. DOI: 10.1177/0363546517746112 Crossref, Medline, Google Scholar
- 32 . Analysis of platelet rich plasma extraction: variations in platelet and blood components between 4 common commercial kits. Orthop J Sports Med 2017; 5(1): DOI: 10.1177/2325967116675272 Medline, Google Scholar
- 33 Platelet-rich plasma injection for the treatment of hamstring injuries: a systematic review and meta-analysis with best-worst case analysis. Am J Sports Med 2021; 49(2):529–537. DOI: 10.1177/0363546520916729 Crossref, Medline, Google Scholar
- 34 Platelet-rich plasma versus corticosteroids for plantar fasciitis: a systematic review of randomized controlled trials. Orthop J Sports Med 2020; 8(4):2325967120915704 DOI: 10.1177/2325967120915704 Crossref, Google Scholar
- 35 The clinical relevance of treating chronic wounds with an enhanced near-physiological concentration of platelet-rich plasma gel. Adv Skin Wound Care 2011; 24(8):357–368. DOI: 10.1097/01.ASW.0000403249.85131.6f Crossref, Medline, Google Scholar